These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27557398)

  • 21. Dissolving undercut microneedle arrays for multicomponent cutaneous vaccination.
    Balmert SC; Carey CD; Falo GD; Sethi SK; Erdos G; Korkmaz E; Falo LD
    J Control Release; 2020 Jan; 317():336-346. PubMed ID: 31756393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural analysis and simulation of solid microneedle array for vaccine delivery applications.
    S B V J C; Mannayee G
    Mater Today Proc; 2022; 65():3774-3779. PubMed ID: 35855948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccination with human papillomavirus pseudovirus-encapsidated plasmids targeted to skin using microneedles.
    Kines RC; Zarnitsyn V; Johnson TR; Pang YY; Corbett KS; Nicewonger JD; Gangopadhyay A; Chen M; Liu J; Prausnitz MR; Schiller JT; Graham BS
    PLoS One; 2015; 10(3):e0120797. PubMed ID: 25785935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microneedle-mediated delivery of viral vectored vaccines.
    Zaric M; Ibarzo Yus B; Kalcheva PP; Klavinskis LS
    Expert Opin Drug Deliv; 2017 Oct; 14(10):1177-1187. PubMed ID: 27591122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of geometrical effects of microneedles on skin penetration by CT scan and finite element analysis.
    Loizidou EZ; Inoue NT; Ashton-Barnett J; Barrow DA; Allender CJ
    Eur J Pharm Biopharm; 2016 Oct; 107():1-6. PubMed ID: 27373753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A simple method of microneedle array fabrication for transdermal drug delivery.
    Kochhar JS; Goh WJ; Chan SY; Kang L
    Drug Dev Ind Pharm; 2013 Feb; 39(2):299-309. PubMed ID: 22519721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IgG-loaded hyaluronan-based dissolving microneedles for intradermal protein delivery.
    Mönkäre J; Reza Nejadnik M; Baccouche K; Romeijn S; Jiskoot W; Bouwstra JA
    J Control Release; 2015 Nov; 218():53-62. PubMed ID: 26437262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcutaneous immunization of Streptococcus suis bacterin using dissolving microneedles.
    Hsueh KJ; Chen MC; Cheng LT; Lee JW; Chung WB; Chu CY
    Comp Immunol Microbiol Infect Dis; 2017 Feb; 50():78-87. PubMed ID: 28131383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transdermal drug delivery using disk microneedle rollers in a hairless rat model.
    Kim HM; Lim YY; An JH; Kim MN; Kim BJ
    Int J Dermatol; 2012 Jul; 51(7):859-63. PubMed ID: 22715835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microneedle technology for potential SARS-CoV-2 vaccine delivery.
    McNamee M; Wong S; Guy O; Sharma S
    Expert Opin Drug Deliv; 2023 Jun; 20(6):799-814. PubMed ID: 37128730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Universal Applicator for Digitally-Controlled Pressing Force and Impact Velocity Insertion of Microneedles into Skin.
    Leone M; van Oorschot BH; Nejadnik MR; Bocchino A; Rosato M; Kersten G; O'Mahony C; Bouwstra J; van der Maaden K
    Pharmaceutics; 2018 Nov; 10(4):. PubMed ID: 30388786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Microneedle-based percutaneous immunity: a review].
    Li Y; Wang J; Jin Z; Wan W; Bai X; Hu C; Li Y; Xin W; Kang L; Yang H; Wang J; Gao S
    Sheng Wu Gong Cheng Xue Bao; 2022 Sep; 38(9):3301-3315. PubMed ID: 36151801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microneedle-mediated vaccine delivery: harnessing cutaneous immunobiology to improve efficacy.
    Al-Zahrani S; Zaric M; McCrudden C; Scott C; Kissenpfennig A; Donnelly RF
    Expert Opin Drug Deliv; 2012 May; 9(5):541-50. PubMed ID: 22475249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progress in microneedle array patch (MAP) for vaccine delivery.
    Nguyen TT; Oh Y; Kim Y; Shin Y; Baek SK; Park JH
    Hum Vaccin Immunother; 2021 Jan; 17(1):316-327. PubMed ID: 32667239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro transdermal delivery of therapeutic antibodies using maltose microneedles.
    Li G; Badkar A; Nema S; Kolli CS; Banga AK
    Int J Pharm; 2009 Feb; 368(1-2):109-15. PubMed ID: 18996461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of PLGA nanoparticle loaded dissolving microneedles and comparison with hollow microneedles in intradermal vaccine delivery.
    Mönkäre J; Pontier M; van Kampen EEM; Du G; Leone M; Romeijn S; Nejadnik MR; O'Mahony C; Slütter B; Jiskoot W; Bouwstra JA
    Eur J Pharm Biopharm; 2018 Aug; 129():111-121. PubMed ID: 29803720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydrodynamic gene delivery in human skin using a hollow microneedle device.
    Dul M; Stefanidou M; Porta P; Serve J; O'Mahony C; Malissen B; Henri S; Levin Y; Kochba E; Wong FS; Dayan C; Coulman SA; Birchall JC
    J Control Release; 2017 Nov; 265():120-131. PubMed ID: 28254630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toward Biofunctional Microneedles for Stimulus Responsive Drug Delivery.
    Cahill EM; O'Cearbhaill ED
    Bioconjug Chem; 2015 Jul; 26(7):1289-96. PubMed ID: 26020359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of the delivery systems using a microneedle array on the permeation of a hydrophilic molecule, calcein.
    Oh JH; Park HH; Do KY; Han M; Hyun DH; Kim CG; Kim CH; Lee SS; Hwang SJ; Shin SC; Cho CW
    Eur J Pharm Biopharm; 2008 Aug; 69(3):1040-5. PubMed ID: 18411045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo assessment of safety of microneedle arrays in human skin.
    Bal SM; Caussin J; Pavel S; Bouwstra JA
    Eur J Pharm Sci; 2008 Oct; 35(3):193-202. PubMed ID: 18657610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.